Stay updated on Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry, 'Revision: v3.5.4', was added to the record history. This updates the page's version label from the previous v3.5.3.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRecord History now lists Revision: v3.5.3 as the latest version, replacing v3.5.2. This indicates an updated version of the study record has been posted.SummaryDifference0.1%

- Check47 days agoChange DetectedThe history now includes the addition of Revision: v3.5.2 and the deletion of Revision: v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision history updated with a new entry for v3.5.0 and the v3.4.3 entry removed.SummaryDifference0.1%

- Check83 days agoChange DetectedThe history page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check111 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and an operating-status notice and an older revision (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.